Open Access Article
Mohamed A. B.
Mostafa
,
Angus E.
McMillan
and
Andrew
Sutherland
*
WestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, UK. E-mail: Andrew.Sutherland@glasgow.ac.uk
First published on 14th March 2017
The amino substituted bicyclo[4.3.0]nonane is a molecular scaffold found in a wide range of natural products and medicinal agents. Despite this, synthetic methods for the general preparation of this structural motif are sparse. Here we evaluate a diastereoselective approach for the preparation of vinylsilyl derived aminobicyclo[4.3.0]nonanes using a one-pot multi-bond forming process involving a Pd(II)-catalysed Overman rearrangement, a Ru(II)-catalysed ring closing enyne metathesis reaction, followed by a hydrogen bonding directed Diels–Alder reaction. We show that a benzyldimethylsilyl-substituted alkene analogue is amenable to further functionalisation and the late stage generation of diverse sp3-rich, drug-like aminobicyclo[4.3.0]nonane scaffolds with up to six stereogenic centres.
With the aim of developing new strategies for the preparation of drug-like scaffolds, we reported a one-pot, three-step multi-bond forming process of alkyne derived allylic alcohols that utilised an Overman rearrangement, a ring closing enyne metathesis (RCEYM) step and a Diels–Alder reaction for the general preparation of aminobicyclo[4.3.0]nonanes.10 More recently the diversity of this library was extended by using C-7 substituted hept-2-en-6-yn-1-ols (Scheme 1a).11 As well as yielding aminobicyclo[4.3.0]nonanes with additional functionality, the presence of a C-7 substituent within the allylic trichloroacetimidate substrate, allowed the use of mild palladium(II)-catalysed conditions for the Overman rearrangement step.12 Although diversity could be introduced into the aminobicyclo[4.3.0]nonane core during the final-stage Diels–Alder reaction, the other point of diversity was via a Sonogashira reaction during the first step. This required substantial effort to generate a small library of these compounds with various R-groups. To overcome this limitation, we decided to investigate an alternative C-7 substituent that would be compatible with the synthesis of alkyne-derived allylic trichloroacetimidates, allow a Pd(II)-catalysed Overman rearrangement and be used as a functional handle for late-stage diversification.
We now report the use of alkynylsilyl derived allylic trichloroacetimidates as substrates for the one-pot multi-bond forming process and the diastereoselective synthesis of aminobicyclo[4.3.0]nonanes bearing a vinylsilane functional handle (Scheme 1b). We also demonstrate the synthetic utility of a benzyldimethylsilyl (BDMS) analogue for the late-stage synthesis of a small library of novel, drug-like aminobicyclo[4.3.0]nonanes with up to six stereogenic centres.
Having prepared the alkynylsilyl derived allylic alcohols, conditions for an optimal one-pot synthesis of the corresponding aminobicyclo[4.3.0]nonanes were next explored. The TBDMS-analogue that was designed to probe the steric limitation of the one-pot process was initially investigated (Scheme 3). The allylic trichloroacetimidate was formed by reaction of 14 with trichloroacetonitrile and DBU and without purification,20 this was subjected to the one-pot three-step process. In our previous study that evaluated C-7 substituted alkyne derived allylic alcohols for the one-pot process, it was found that while a relatively bulky substituent prevented coordination of the Pd(II)-catalyst to the alkyne and facilitated an efficient Overman rearrangement, the presence of this group hindered the following RCEYM step.11b With the TBDMS-derived allylic trichloroacetimidate, a similar outcome was observed for both steps. The Pd(II)-catalysed Overman rearrangement proceeded under standard conditions to give the allylic trichloroacetamide after 12 hours,21 however, the RCEYM reaction required forcing conditions. A combination of the use of 1,7-octadiene (an in situ source of ethylene) to accelerate the reaction,22 high loading of Grubbs 2nd generation catalyst (20 mol%) and a 120 hour reaction time was required for complete conversion to the enyne.23 Following the hydrogen bonding directed Diels–Alder reaction with N-phenyl maleimide, aminobicyclo[4.3.0]nonane 16 was isolated as a single diastereomer in 19% yield over the four steps. This relatively low yield is likely due to the extended RCEYM step and demonstrates the steric limitation of the one-pot process.
Application of the one-pot process using BDMS-allylic alcohol 15 was more straightforward (Scheme 3). Again, allylic trichloroacetimidate formation and Pd(II)-catalysed Overman rearrangement proceeded under standard conditions. The RCEYM reaction did require the presence of 1,7-octadiene, but needed only 7 mol% catalyst loading and was complete after 18 hours. Diels–Alder reaction with N-phenyl maleimide then gave aminobicyclo[4.3.0]nonane 17 as a single diastereomer in 57% yield over the four steps. As previously reported for the Diels–Alder reaction of trichloroacetamide derived cyclic exo-dienes, the reaction proceeds via a hydrogen bonding controlled endo transition state, forming the syn-products (syn relationship of hydrogen atoms at C-3a, C-8, C-8a and C-8b) with excellent diastereoselectivity (>20
:
1).10,11 Analysis of BDMS-derived aminobicyclo[4.3.0]nonane 17 using difference NOE experiments confirmed the relative stereochemistry and that the Diels–Alder reaction has proceeded in the same manner as other trichloroacetamide derived cyclic exo-diene substrates (Scheme 3).24
Having used the BDMS-group to perform a mild Pd(II)-catalysed Overman rearrangement and efficiently access the aminobicyclo[4.3.0]nonane core, we next wanted to demonstrate that the resulting vinylsilane could be used for the late-stage synthesis of a wide range of derivatives. Initially, removal of the trialkylsilyl group to access the parent scaffold was investigated (Scheme 4). During introduction of the BDMS-group for cross-coupling reactions, Trost and co-workers showed that BDMS-vinylsilanes were stable to proto-desilylation under typical fluoride conditions.14 This was confirmed on treatment of vinylsilane 17 with TBAF, which showed no reaction. Increasing the temperature or duration of the reaction only led to decomposition. Cleavage of the C–Si bond was achieved under acidic conditions. While the use of dilute hydrochloric acid solutions (2 M or 4 M) gave only partial proto-desilylation, treatment of 17 with 6 M hydrochloric acid at 60 °C gave 18 cleanly, in 74% yield. The reactivity of tri-substituted alkene 18 to oxidation was next studied. Osmium tetroxide mediated dihydroxylation under Donohoe conditions gave the desired diol product 19 as a single diastereomer in 86% yield.25 In a similar fashion, treatment of 18 with m-CPBA proceeded with high selectivity and the major diastereomer 20 was isolated in 73% yield.26,27 The high selectivity for both reactions is a consequence of the relative stereochemistry at the C-3a, C-8, C-8a and C-8b positions of the tricyclic core of 18. This creates a curved shape to the molecule where reactions readily take place at the more exposed convex face.
The final stage of this project then investigated cross-coupling reactions of vinylsilane 17 for the late-stage diversification of the aminobicyclo[4.3.0]nonane core. Using standard conditions for Hiyama–Denmark reactions with the BDMS-group,14 attempts were made to couple 17 with various electron-rich and electron-deficient aryl iodides. However, these reactions showed only decomposition of vinylsilane 17. Due to the inability of 17 to undergo cross-coupling reactions, an alternative strategy was sought using a more reactive vinyl functionality. Iodo-desilylation of vinylsilane 17 was found to proceed readily with iodine monochloride and gave vinyl iodide 21 in 88% yield (Scheme 5).28 This was then used to explore various palladium-catalysed cross-coupling reactions.
After some optimisation, vinyl iodide 21 was found to be an efficient cross-coupling partner for Suzuki–Miyaura reactions. Using Pd(PPh3)4 (10 mol%) and phenylboronic acid under typical conditions gave the cross-coupled product 22 in 76% yield. Reaction of an electron-rich variant, p-methoxyphenylboronic acid also proceed smoothly, giving 23 in 53% yield. In previous studies, we have found that the trichloroacetamide group is prone to dechlorination during Pd(0)-catalysed reactions.11b,29 Similarly, in the Suzuki–Miyaura reactions to form 22 and 23, small amounts of dichloroacetamide analogues of these compounds were observed in the reaction mixture (<10%). This became a more significant issue in attempting a cross-coupling reaction with electron-defficient p-fluorophenylboronic acid, where substantial amounts of the reduced coupled product were also detected (∼20%). However, this by-product could be minimised (<10%) by using a shorter reaction time, which allowed the synthesis of 24 in 46% yield. To expand the diversity of aminobicyclo[4.3.0]nonanes at the C-5 position, a Sonogashira reaction with phenylacetylene was also performed. For this example, both palladium-mediated coupling and reduction of the trichloroacetamide were found to be rapid, leading to isolation of the dichloroacetamide-derived enyne 25 as the major product, in 48% yield.
:
1) gave 5-(tert-butyldimethylsilyl)pent-4-yn-1-ol (8) (0.036 g, 31%) as a colourless oil. Spectroscopic data were consistent with the literature.30δH (400 MHz, CDCl3) 0.06 (6H, s, Si(CH3)2), 0.90 (9H, s, SiC(CH3)3), 1.75 (2H, quin., J 6.5 Hz, 2-H2), 1.99 (1H, br s, OH), 2.34 (2H, t, J 6.5 Hz, 3-H2), 3.74 (2H, t, J 6.5 Hz, 1-H2); δC (101 MHz, CDCl3) −4.5 (2 × CH3), 16.5 (C), 16.5 (CH2), 26.1 (3 × CH3), 31.3 (CH2), 61.8 (CH2), 83.3 (C), 107.2 (C); m/z (ESI) 221 (MNa+. 100%).
:
1) gave 1-(tetrahydropyran-2′-yloxy)-4-pentyne (9) (1.81 g, 100%) as a colourless oil. Spectroscopic data were consistent with the literature.31δH (400 MHz, CDCl3) 1.46–1.86 (8H, m, 2-H2, 3′-H2, 4′-H2 and 5′-H2), 1.94 (1H, t, J 2.7 Hz, 5-H), 2.28–2.35 (2H, m, 3-H2), 3.45–3.55 (2H, m, 1-HH and 6′-HH), 3.80–3.91 (2H, m, 1-HH and 6′-HH), 4.60 (1H, t, J 3.3 Hz, 2′-H); δC (101 MHz, CDCl3) 15.1 (CH2), 19.2 (CH2), 25.4 (CH2), 28.6 (CH2), 30.4 (CH2), 61.7 (CH2), 65.4 (CH2), 68.5 (CH), 83.6 (C), 98.4 (CH); m/z (EI) 168 (M+. 4%), 149 (8), 125 (11), 111 (12), 84 (74), 67 (28), 49 (100).
:
2) gave 5-(benzyldimethylsilyl)-1-(tetrahydropyran-2′-yloxy)-4-pentyne (10) (1.84 g, 100%) as a colourless oil. Spectroscopic data were consistent with the literature.32δH (400 MHz, CDCl3) 0.10 (6H, s, Si(CH3)2), 1.47–1.87 (8H, m, 2-H2, 3′-H2, 4′-H2 and 5′-H2), 2.18 (2H, s, SiCH2), 2.35 (2H, t, J 7.1 Hz, 3-H2), 3.42–3.54 (2H, m, 1-HH and 6′-HH), 3.79–3.91 (2H, m, 1-HH and 6′-HH), 4.60 (1H, t, J 3.3 Hz, 2′-H), 7.05–7.12 (3H, m, 3 × ArH), 7.19–7.25 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (2 × CH3), 18.7 (CH2), 21.4 (CH2), 27.4 (CH2), 28.4 (CH2), 30.7 (CH2), 32.6 (CH2), 64.0 (CH2), 67.7 (CH2), 85.0 (C), 100.6 (CH), 110.2 (C), 126.2 (CH), 130.0 (2 × CH), 130.3 (2 × CH), 141.1 (C); m/z (ESI) 339 (MNa+. 100%).
:
1) gave 5-(benzyldimethylsilyl)pent-4-yn-1-ol (11) (0.065 g, 100%) as a colourless oil. Spectroscopic data were consistent with the literature.17δH (400 MHz, CDCl3) 0.12 (6H, s, Si(CH3)2), 1.76 (2H, quin., J 6.5 Hz, 2-H2), 1.86 (1H, s, OH), 2.19 (2H, s, SiCH2), 2.35 (2H, t, J 6.5 Hz, 3-H2), 3.72 (2H, t, J 6.5 Hz, 1-H2), 7.06–7.13 (3H, m, 3 × ArH), 7.21–7.27 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (2 × CH3), 18.4 (CH2), 28.4 (CH2), 33.0 (CH2), 63.6 (CH2), 85.5 (C), 110.0 (C), 126.2 (CH), 130.0 (2 × CH), 130.3 (2 × CH), 141.1 (C); m/z (ESI) 255 (MNa+. 100%).
:
3) gave ethyl (2E)-7-(tert-butyldimethylsilyl)hept-2-en-6-ynoate (12) (0.211 g, 80%) as a colourless oil. νmax/cm−1 (neat) 2929 (CH), 2364, 1723 (C
O), 1472, 1250, 1040, 837; δH (400 MHz, CDCl3) 0.07 (6H, s, Si(CH3)2), 0.91 (9H, s, SiC(CH3)3), 1.28 (3H, t, J 7.1 Hz, OCH2CH3), 2.34–2.45 (4H, m, 4-H2 and 5-H2), 4.18 (2H, q, J 7.1 Hz, OCH2CH3), 5.88 (1H, d, J 15.7 Hz, 2-H), 6.97 (1H, dt, J 15.7, 6.6 Hz, 3-H); δC (101 MHz, CDCl3) −4.6 (2 × CH3), 14.2 (CH3), 16.4 (C), 18.8 (CH2), 26.0 (3 × CH3), 31.3 (CH2), 60.2 (CH2), 84.0 (C), 105.8 (C), 122.5 (CH), 146.5 (CH), 166.3 (C); m/z (ESI) 289.1590 (MNa+. C15H26NaO2Si requires 289.1594).
:
2) gave ethyl (2E)-7-(benzyldimethylsilyl)hept-2-en-6-ynoate (13) (1.19 g, 92%) as a colourless oil. νmax/cm−1 (neat) 2958 (CH), 1720 (C
O), 1656 (C
C), 1494, 1249, 1154, 1039, 833, 758; δH (400 MHz, CDCl3) 0.10 (6H, s, Si(CH3)2), 1.29 (3H, t, J 7.1 Hz, OCH2CH3), 2.18 (2H, s, SiCH2), 2.34–2.45 (4H, m, 4-H2 and 5-H2), 4.20 (2H, q, J 7.1 Hz, OCH2CH3), 5.87 (1H, dt, J 15.7, 1.4 Hz, 2-H), 6.97 (1H, dt, J 15.7, 6.6 Hz, 3-H), 7.03–7.12 (3H, m, 3 × ArH), 7.19–7.25 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (2 × CH3), 16.3 (CH3), 20.8 (CH2), 28.3 (CH2), 33.1 (CH2), 62.2 (CH2), 86.3 (C), 108.8 (C), 124.5 (CH), 126.3 (CH), 130.1 (2 × CH), 130.3 (2 × CH), 141.0 (C), 148.4 (CH), 168.2 (C); m/z (ESI) 323.1422 (MNa+. C18H24NaO2Si requires 323.1438).
:
2) gave (2E)-7-(tert-butyldimethylsilyl)hept-2-en-6-yn-1-ol (14) (0.128 g, 92%) as a colourless oil. νmax/cm−1 (neat) 3332 (OH), 2929 (CH), 2174, 1472, 1250, 1007, 968, 837, 825, 774; δH (400 MHz, CDCl3) 0.07 (6H, s, Si(CH3)2), 0.92 (9H, s, SiC(CH3)3), 1.32 (1H, br s, OH), 2.23–2.39 (4H, m, 4-H2 and 5-H2), 4.09 (2H, br t, J 4.6 Hz, 1-H2), 5.66–5.78 (2H, m, 2-H and 3-H); δC (101 MHz, CDCl3) −4.5 (2 × CH3), 16.5 (C), 19.9 (CH2), 26.0 (3 × CH3), 31.5 (CH2), 63.5 (CH2), 83.1 (C), 107.0 (C), 130.4 (CH), 130.8 (CH); m/z (ESI) 247.1479 (MNa+. C13H24NaOSi requires 247.1489).
:
1) gave (2E)-7-(benzyldimethylsilyl)hept-2-en-6-yn-1-ol (15) (1.14 g, 98%) as a colourless oil. νmax/cm−1 (neat) 3367 (OH), 2922 (CH), 2175, 1494, 1249, 838, 762, 698; δH (500 MHz, CDCl3) 0.11 (6H, s, Si(CH3)2), 1.43 (1H, br s, OH), 2.18 (2H, s, SiCH2), 2.23–2.34 (4H, m, 4-H2 and 5-H2), 4.10 (2H, d, J 4.4 Hz, 1-H2), 5.65–5.76 (2H, m, 2-H and 3-H), 7.06–7.12 (3H, m, 3 × ArH), 7.20–7.25 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (2 × CH3) 21.8 (CH2), 28.4 (CH2), 33.2 (CH2), 65.4 (CH2), 85.5 (C), 109.9 (C), 126.2 (CH), 130.0 (2 × CH), 130.3 (2 × CH), 132.3 (CH), 132.6 (CH), 141.1 (C); m/z (ESI) 281.1323 (MNa+. C16H22NaOSi requires 281.1332).
:
2) gave (3aS*,8R*,8aS*,8bR*)-5-(tert-butyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (16) (0.025 g, 19%) as a yellow oil. νmax/cm−1 (neat) 3319 (NH), 2954 (CH), 1699 (C
O), 1517 (C
C), 1388, 1199, 827, 755; δH (400 MHz, CDCl3) 0.08 (3H, s, SiCH3), 0.15 (3H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.83 (1H, ddd, J 18.6, 12.4, 7.6 Hz, 7-HH), 2.12–2.21 (2H, m, 4-HH and 7-HH), 2.24–2.38 (1H, m, 6-HH), 2.65 (1H, dd, J 16.5, 7.6 Hz, 6-HH), 2.92–2.98 (1H, m, 8a-H), 3.01 (1H, dd, J 14.8, 1.3 Hz, 4-HH), 3.32 (1H, ddd, J 8.9, 7.2, 1.3 Hz, 3a-H), 3.40 (1H, dd, J 8.9, 6.3 Hz, 8b-H), 4.77–4.88 (1H, m, 8-H), 7.12–7.17 (2H, m, 2 × ArH), 7.37–7.50 (3H, m, 3 × ArH), 8.84 (1H, d, J 9.6 Hz, NH); δC (126 MHz, CDCl3) −5.1 (CH3), −4.2 (CH3), 18.3 (C), 26.8 (3 × CH3), 30.3 (CH2), 30.5 (CH2), 31.9 (CH2), 39.3 (CH), 40.6 (CH), 43.1 (CH), 52.3 (CH), 92.9 (C), 126.4 (2 × CH), 128.8 (C), 129.0 (CH), 129.3 (2 × CH), 131.5 (C), 156.1 (C), 162.3 (C), 178.1 (C), 179.8 (C); m/z (ESI) 563.1045 (MNa+. C25H3135Cl3N2NaO3Si requires 563.1062).
:
1) gave (3aS*,8R*,8aS*,8bR*)-5-(benzyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (17) (0.631 g, 57%) as a yellow oil. νmax/cm−1 (neat) 3313 (NH), 3023 (CH), 2957 (CH), 1698 (C
O), 1518 (C
C), 1389, 1198, 830, 754; δH (500 MHz, CDCl3) 0.05 (3H, s, SiCH3), 0.09 (3H, s, SiCH3), 1.73–1.89 (1H, m, 7-HH), 2.06–2.27 (5H, m, SiCH2, 4-HH, 6-HH and 7-HH), 2.52 (1H, dd, J 16.5, 7.6 Hz, 6-HH), 2.90–2.96 (1H, m, 8a-H), 2.99 (1H, dd, J 14.7, 1.6 Hz, 4-HH), 3.34 (1H, ddd, J 8.9, 6.8, 1.6 Hz, 3a-H), 3.42 (1H, dd, J 8.9, 6.5 Hz, 8b-H), 4.75–4.88 (1H, m, 8-H), 6.91–6.96 (2H, m, 2 × ArH), 7.04–7.10 (1H, m, ArH), 7.14–7.21 (4H, m, 4 × ArH), 7.38–7.50 (3H, m, 3 × ArH), 8.91 (1H, d, J 9.5 Hz, NH); δC (126 MHz, CDCl3) −3.2 (CH3), −2.6 (CH3), 25.2 (CH2), 29.4 (CH2), 29.8 (CH2), 31.9 (CH2), 39.5 (CH), 40.7 (CH), 43.1 (CH), 52.3 (CH), 92.9 (C), 124.3 (CH), 126.3 (2 × CH), 128.2 (2 × CH), 128.3 (2 × CH), 129.0 (C), 129.1 (CH), 129.4 (2 × CH), 131.5 (C), 139.3 (C), 155.7 (C), 162.3 (C), 178.4 (C), 179.9 (C); m/z (ESI) 597.0898 (MNa+. C28H2935Cl3N2NaO3Si requires 597.0905).
:
3) gave (3aS*,8R*,8aS*,8bR*)-4,6,7,8,8a,8b-hexahydro-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (18) (0.021 g, 74%) as a white solid. Mp 174–176 °C; νmax/cm−1 (neat) 3304 (NH), 2955 (CH), 2924 (CH), 1695 (C
O), 1516 (C
C), 1388, 1288, 1202, 1182, 822, 750; δH (500 MHz, CDCl3) 1.81 (1H, qd, J 12.5, 7.6 Hz, 7-HH), 2.10–2.18 (1H, m, 7-HH), 2.19–2.38 (2H, m, 6-HH and 4-HH), 2.47 (1H, dd, J 16.2, 7.6 Hz, 6-HH), 2.85 (1H, ddd, J 15.1, 7.2, 1.1 Hz, 4-HH), 2.89–2.96 (1H, m, 8a-H), 3.33 (1H, ddd, J 8.7, 7.2, 1.1 Hz, 3a-H), 3.43 (1H, dd, J 8.7, 6.4 Hz, 8b-H), 4.80–4.91 (1H, m, 8-H), 5.75–5.81 (1H, m, 5-H), 7.15–7.20 (2H, m, 2 × ArH), 7.39–7.51 (3H, m, 3 × ArH), 8.95 (1H, d, J 9.2 Hz, NH); δC (126 MHz, CDCl3) 26.1 (CH2), 28.6 (CH2), 31.7 (CH2), 39.4 (CH), 41.2 (CH), 41.5 (CH), 52.9 (CH), 92.9 (C), 117.1 (CH), 126.5 (2 × CH), 129.1 (CH), 129.3 (2 × CH), 131.5 (C), 145.8 (C), 162.3 (C), 178.5 (C), 179.6 (C); m/z (CI) 427.0373 (MH+. C19H1835Cl3N2O3 requires 427.0383), 393 (65%), 359 (100), 325 (65), 311 (20), 266 (25), 174 (25), 113 (25), 71 (73).
:
1) gave (3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-dihydroxy-2-phenyl-3a,4,5,5a,6,7,8a,8b-octahydro-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (19) (0.027 g, 86%) as a white solid. Mp 168–170 °C; νmax/cm−1 (neat) 3471 (OH), 3329 (NH), 2946 (CH), 1698 (C
O), 1515 (C
C), 1386, 1175, 821, 754; δH (500 MHz, CDCl3) 1.61–1.76 (1H, m, 6-HH), 1.85–2.03 (2H, m, 6-HH and 7-HH), 2.09 (1H, dt, J 13.5, 3.7 Hz, 4-HH), 2.18 (1H, ddd, J 13.5, 10.8, 6.7 Hz, 4-HH), 2.41–2.55 (1H, m, 7-HH), 2.70–2.89 (2H, m, 8a-H and OH), 3.00 (1H, br s, OH), 3.22 (1H, dd, J 9.0, 7.1 Hz, 8b-H), 3.35 (1H, ddd, J 9.0, 6.7, 3.7 Hz, 3a-H), 3.62 (1H, d, J 10.8 Hz, 5-H), 5.04–5.16 (1H, m, 8-H), 7.21–7.25 (2H, m, 2 × ArH), 7.40–7.56 (3H, m, 3 × ArH), 8.56 (1H, d, J 9.5 Hz, NH); δC (126 MHz, CDCl3) 29.7 (CH2), 30.3 (CH2), 37.1 (CH2), 38.6 (CH), 39.3 (CH), 48.1 (CH), 51.9 (CH), 70.1 (CH), 81.9 (C), 92.8 (C), 126.3 (2 × CH), 129.2 (CH), 129.5 (2 × CH), 131.2 (C), 162.1 (C), 178.0 (C), 178.8 (C); m/z (ESI) 483.0242 (MNa+. C19H1935Cl3N2NaO5 requires 483.0252).
:
3) gave (3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-epoxy-3a,4,5,5a,6,7,8a,8b-octahydro-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (20) (0.024 g, 73%) as a light brown solid. Mp 154–156 °C; νmax/cm−1 (neat) 3265 (NH), 2934 (CH), 1697 (C
O), 1520 (C
C), 1394, 1192, 824, 773; δH (500 MHz, CDCl3) 1.65–1.72 (1H, m, 6-HH), 1.94–2.11 (2H, m, 6-HH and 7-HH), 2.23 (1H, dd, J 15.5, 8.5 Hz, 4-HH), 2.26–2.34 (1H, m, 7-HH), 2.77 (1H, dd, J 15.5, 4.1 Hz, 4-HH), 2.96 (1H, dd, J 11.2, 5.0 Hz, 8a-H), 3.05–3.12 (1H, m, 3a-H), 3.17 (1H, dd, J 9.8, 5.0 Hz, 8b-H), 3.59 (1H, d, J 4.1 Hz, 5-H), 4.70–4.82 (1H, m, 8-H), 7.27–7.33 (2H, m, 2 × ArH), 7.38–7.53 (3H, m, 3 × ArH), 9.33 (1H, d, J 9.8 Hz, NH); δC (126 MHz, CDCl3) 25.6 (CH2), 29.1 (CH2), 32.8 (CH2), 38.4 (CH), 40.0 (CH), 40.5 (CH), 50.5 (CH), 56.5 (CH), 67.9 (C), 92.8 (C), 126.7 (2 × CH), 128.9 (CH), 129.3 (2 × CH), 132.3 (C), 162.5 (C), 178.9 (C), 180.3 (C); m/z (ESI) 465.0144 (MNa+. C19H1735Cl3N2NaO4 requires 465.0146).
:
2) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-iodo-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (21) (0.400 g, 88%) as a white solid. Mp 130–132 °C; νmax/cm−1 (neat) 3309 (NH), 2954 (CH), 1698 (C
O), 1517 (C
C), 1391, 1200, 823; δH (400 MHz, CDCl3) 1.86 (1H, qd, J 12.3, 8.2 Hz, 7-HH), 2.12–2.34 (2H, m, 6-HH and 7-HH), 2.46 (1H, dd, J 16.9, 8.2 Hz, 6-HH), 2.84–2.94 (1H, m, 4-HH), 3.02–3.08 (1H, m, 8a-H), 3.28 (1H, dd, J 15.7, 1.2 Hz, 4-HH), 3.37 (1H, ddd, J 8.6, 6.7, 1.2 Hz, 3a-H), 3.42 (1H, dd, J 8.6, 5.8 Hz, 8b-H), 4.86–4.99 (1H, m, 8-H), 7.16–7.21 (2H, m, 2 × ArH), 7.41–7.53 (3H, m, 3 × ArH), 8.84 (1H, d, J 9.6 Hz, NH); δC (101 MHz, CDCl3) 30.6 (CH2), 33.6 (CH2), 39.8 (CH2), 40.6 (CH), 41.1 (CH), 44.5 (CH), 53.9 (CH), 82.0 (C), 92.8 (C), 126.5 (2 × CH), 129.3 (CH), 129.4 (2 × CH), 131.4 (C), 151.0 (C), 162.1 (C), 177.0 (C), 178.9 (C); m/z (ESI) 574.9151 (MNa+. C19H1635Cl3IN2NaO3 requires 574.9163).
:
1 mixture of toluene/methanol (3 mL) at room temperature was added phenylboronic acid (0.008 g, 0.070 mmol), tetrakis(triphenylphosphine)palladium(0) (0.005 g, 0.005 mmol) and sodium carbonate (0.025 g, 0.180 mmol). The reaction mixture was heated to 70 °C and stirred for 48 h. The mixture was allowed to cool to room temperature and then concentrated in vacuo. The residue was dissolved in ethyl acetate (5 mL), washed with water (5 mL), brine (5 mL), dried (MgSO4), and then concentrated in vacuo. Flash column chromatography (petroleum ether/diethyl ether, 7
:
3) gave (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (22) (0.017 g, 76%) as a yellow solid. Mp 151–153 °C; νmax (neat) 3358 (NH), 2936 (CH), 1695 (C
O), 1517, 1498, 1387, 1154, 822 cm−1; δH (400 MHz, CDCl3) 1.75 (1H, dq, J 12.3, 10.2 Hz, 7-HH), 2.10–2.20 (1H, m, 7-HH), 2.53–2.66 (3H, m, 4-HH and 6-H2), 3.12 (1H, dd, J 9.1, 5.8 Hz, 8a-H), 3.30 (1H, dd, J 15.2, 1.4 Hz, 4-HH), 3.46–3.56 (2H, m, 3a-H and 8b-H), 4.88–5.01 (1H, m, 8-H), 7.06–7.10 (2H, m, 2 × ArH), 7.23–7.47 (8H, m, 8 × ArH), 8.96 (1H, d, J 9.6 Hz, NH); δC (126 MHz, CDCl3) 28.4 (CH2), 31.6 (CH2), 31.7 (CH2), 40.3 (CH), 41.7 (CH), 43.7 (CH), 52.9 (CH), 93.0 (C), 126.6 (2 × CH), 127.2 (CH), 127.5 (2 × CH), 128.5 (2 × CH), 129.2 (CH), 129.4 (2 × CH), 130.2 (C), 131.5 (C), 139.0 (C), 139.7 (C), 162.3 (C), 178.6 (C), 179.8 (C); m/z (ESI) 525 ([MNa]+. 100%), 481 (18), 454 (7), 413 (7), 345 (24), 323 (21), 297 (9), 236 (11), 218 (7), 196 (6); m/z (ESI) 525.0947 (MNa+. C25H2135Cl3N2NaO3 requires 525.0510).
:
2) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4′′-methoxyphenyl)-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (23) (0.013 g, 53%) as a yellow solid. Mp 115–117 °C; νmax/cm−1 (neat) 3308 (NH), 2959 (CH), 1698 (C
O), 1512 (C
C), 1391, 1247, 823; δH (400 MHz, CDCl3) 1.66–1.81 (1H, m, 7-HH), 2.09–2.19 (1H, m, 7-HH), 2.52–2.62 (3H, m, 4-HH and 6-H2), 3.10 (1H, dd, J 8.9, 6.3 Hz, 8a-H), 3.27 (1H, dd, J 15.2, 1.2 Hz, 4-HH), 3.44–3.54 (2H, m, 3a-H and 8b-H), 3.81 (3H, s, OCH3), 4.87–4.99 (1H, m, 8-H), 6.85–6.92 (2H, m, 3′′-H and 5′′-H), 7.04–7.09 (2H, m, 2 × ArH), 7.17–7.23 (2H, m, 2′′-H and 6′′-H), 7.34–7.46 (3H, m, 3 × ArH), 8.97 (1H, d, J 9.6 Hz, NH); δC (101 MHz, CDCl3) 28.3 (CH2), 31.6 (CH2), 31.7 (CH2), 40.3 (CH), 41.7 (CH), 43.7 (CH), 52.9 (CH), 55.3 (CH3), 92.9 (C), 113.8 (2 × CH), 126.5 (2 × CH), 128.7 (2 × CH), 129.1 (CH), 129.4 (2 × CH), 129.8 (C), 131.4 (C), 131.4 (C), 138.1 (C), 158.7 (C), 162.3 (C), 178.6 (C), 179.8 (C); m/z (ESI) 555.0599 (MNa+. C26H2335Cl3N2NaO4 requires 555.0616).
:
1) gave (3aS*,8R*,8aS*,8bR*)-5-(4′′-fluorophenyl)-3a,4,6,7,8a,8b-hexahydro-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (24) (0.013 g, 46%) as a white solid. Mp 124–126 °C; νmax/cm−1 (neat) 3312 (NH), 2926 (CH), 1700 (C
O), 1510 (C
C), 1500, 1391, 838, 756; δH (500 MHz, CDCl3) 1.69–1.82 (1H, m, 7-HH), 2.12–2.20 (1H, m, 7-HH), 2.48–2.66 (3H, m, 4-HH and 6-H2), 3.12 (1H, dd, J 8.6, 6.6 Hz, 8a-H), 3.25 (1H, dd, J 15.2, 1.2 Hz, 4-HH), 3.45–3.56 (2H, m, 3a-H and 8b-H), 4.88–4.98 (1H, m, 8-H), 7.00–7.09 (4H, m, 3′′-H, 5′′-H and 2 × ArH), 7.19–7.25 (2H, m, 2′′-H and 6′′-H), 7.37–7.48 (3H, m, 3 × ArH), 8.95 (1H, d, J 9.6 Hz, NH); δC (126 MHz, CDCl3) 28.3 (CH2), 31.7 (CH2), 31.7 (CH2), 40.3 (CH), 41.6 (CH), 43.7 (CH), 52.8 (CH), 92.9 (C), 115.4 (2 × CH, 2JCF 21.4 Hz), 126.5 (2 × CH), 129.2 (2 × CH, 3JCF 8.0 Hz), 129.2 (CH), 129.4 (2 × CH), 129.4 (C), 131.4 (C), 134.9 (C, 4JCF 3.2 Hz), 139.6 (C), 161.8 (C, 1JCF 247.3 Hz), 162.3 (C), 178.5 (C), 179.7 (C); m/z (ESI) 543.0393 (MNa+. C25H20F35Cl3N2NaO3 requires 543.0416).
:
2) to give (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(phenylethynyl)-2-phenyl-8-(2′,2′-dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (25) (0.007 g, 48%) as a colourless oil. νmax/cm−1 (neat) 3021 (CH), 2361, 1705 (C
O), 1522 (C
C), 1393, 1215, 754; δH (400 MHz, CDCl3) 1.78–1.92 (1H, m, 7-HH), 2.09–2.22 (1H, m, 7-HH), 2.35–2.57 (2H, m, 4-HH and 6-HH), 2.84 (1H, dd, J 17.6, 7.7 Hz, 6-HH), 2.99–3.02 (1H, m, 8a-H), 3.06 (1H, dd, J 15.0, 1.3 Hz, 4-HH), 3.39 (1H, ddd, J 8.8, 7.7, 1.3 Hz, 3a-H), 3.47 (1H, dd, J 8.8, 6.3 Hz, 8b-H), 4.94 (1H, dtd, J 12.3, 9.8, 7.1 Hz, 8-H), 5.97 (1H, s, CHCl2), 7.18–7.23 (2H, m, 2 × ArH), 7.29–7.34 (3H, m, 3 × ArH), 7.38–7.53 (5H, m, 5 × ArH), 8.58 (1H, d, J 9.8 Hz, NH); δC (101 MHz, CDCl3) 28.7 (CH2), 31.0 (CH2), 31.3 (CH2), 39.4 (CH), 41.1 (CH), 42.8 (CH), 51.7 (CH), 66.6 (CH), 86.7 (C), 93.5 (C), 111.8 (C), 123.0 (C), 126.5 (2 × CH), 128.3 (2 × CH), 128.4 (CH), 129.1 (CH), 129.3 (2 × CH), 131.5 (2 × CH), 131.5 (C), 151.4 (C), 164.5 (C), 177.7 (C), 179.0 (C); m/z (ESI) 515.0875 (MNa+. C27H2235Cl2N2NaO3 requires 515.0900).
Footnote |
| † Electronic supplementary information (ESI) available: NOE data for compounds 16–25 and, 1H and 13C NMR spectra of all compounds. See DOI: 10.1039/c7ob00456g |
| This journal is © The Royal Society of Chemistry 2017 |